Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
The FDA does not review or approve dietary supplements before they hit the shelves
The product is not intended for children
Medically unexplained symptoms
Market Dynamics: From Shortages to Price Pressures After prolonged supply constraints, the FDA officially declared US GLP-1 shortages resolved in April 2025, removing semaglutide and tirzepatide from its shortage list and ending enforcement discretion for compounded versions by May 2025
US$ 27.60
US$ 23.84
US$ 26.51
US$ 21.08
US$ 20.49
US$ 26.23
US$ 22.62
US$ 26.65
US$ 29.23
US$ 21.74
US$ 24.15
